24 janv. 2018 - FDA and the Federal Trade Commission posted joint warning letters to the marketers and distributors of 12 opioid cessation products, for illegally marketing unapproved products with claims about their ability to help in the treatment of opioid addiction and withdrawal.
Ajouté au bande de temps:
Date:
24 janv. 2018
Maintenaint
~ Il y a 6 ans et 4 mois
